DelveInsight's Friedreich's Ataxia Market Insights report includes a comprehensive understanding of current treatment ...

The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe work towards the ...

“We are hosting the cure FA soiree on Saturday, June seventh At the Omni Hotel in Oklahoma City, and this event was born out ...

Eventually, Michael was diagnosed with Friedreich's Ataxia or FA. “Fatigue and weakness and lots of people have heart problems,” said Michael. It is a progressive disease that Michael has been ...

Initial Data from the Ongoing, Blinded Phase 1 Single-Ascending Dose Trial Has Demonstrated Favorable Safety and Pharmacokinetics IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; ...

Researchers have developed a gene editing strategy that can repair the genetic problems that lead to Huntington's disease and Friedreich's ataxia. | Genetics And Genomics ...

First consumer products roll out in Q3 2025, creating near-term revenue potential and marking a new chapter in Jupiter's evolution Jupiter, Florida, June 09, 2025 (GLOBE NEWSWIRE) -- Jupiter Neuroscie ...

The Nugevia launch adds a new dimension to Jupiter's value proposition as a dual-path company-advancing clinical-stage therapies for CNS disorders while monetizing its platform in the booming ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.